Brokerages forecast that The Ensign Group, Inc. (NASDAQ:ENSG) will announce $510.90 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for The Ensign Group’s earnings. The lowest sales estimate is $505.30 million and the highest is $516.50 million. The Ensign Group reported sales of $471.59 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 8.3%. The company is expected to issue its next quarterly earnings report on Wednesday, November 14th.

According to Zacks, analysts expect that The Ensign Group will report full year sales of $2.03 billion for the current year, with estimates ranging from $2.01 billion to $2.04 billion. For the next fiscal year, analysts anticipate that the company will post sales of $2.19 billion per share, with estimates ranging from $2.18 billion to $2.19 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research firms that cover The Ensign Group.

The Ensign Group (NASDAQ:ENSG) last posted its earnings results on Thursday, August 2nd. The company reported $0.44 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.01. The business had revenue of $496.40 million for the quarter, compared to the consensus estimate of $496.61 million. The Ensign Group had a net margin of 3.61% and a return on equity of 15.61%. The company’s revenue for the quarter was up 10.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.23 EPS.

ENSG has been the topic of a number of research reports. ValuEngine raised shares of The Ensign Group from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, May 1st. Stifel Nicolaus raised their target price on shares of The Ensign Group from $22.00 to $26.00 and gave the company a “hold” rating in a research report on Thursday, May 3rd. Cantor Fitzgerald raised their target price on shares of The Ensign Group to $35.00 and gave the company an “overweight” rating in a research report on Friday, May 4th. Citigroup raised their target price on shares of The Ensign Group from $31.00 to $39.00 and gave the company an “outperform” rating in a research report on Tuesday, May 22nd. Finally, Oppenheimer raised their target price on shares of The Ensign Group from $31.00 to $39.00 and gave the company an “outperform” rating in a research report on Tuesday, May 22nd. Two analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $36.50.

NASDAQ ENSG traded down $0.11 during trading on Friday, reaching $37.06. 400 shares of the company’s stock traded hands, compared to its average volume of 252,260. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.42 and a current ratio of 1.42. The company has a market capitalization of $1.87 billion, a price-to-earnings ratio of 30.89, a price-to-earnings-growth ratio of 1.40 and a beta of 0.62. The Ensign Group has a 12-month low of $19.40 and a 12-month high of $40.09.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, July 31st. Stockholders of record on Saturday, June 30th were given a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.49%. The ex-dividend date was Thursday, June 28th. The Ensign Group’s payout ratio is currently 15.00%.

In other news, CEO Christopher R. Christensen sold 21,241 shares of The Ensign Group stock in a transaction that occurred on Monday, July 16th. The shares were sold at an average price of $37.42, for a total value of $794,838.22. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Suzanne D. Snapper sold 3,273 shares of The Ensign Group stock in a transaction that occurred on Wednesday, May 23rd. The stock was sold at an average price of $35.00, for a total transaction of $114,555.00. Following the completion of the transaction, the chief financial officer now directly owns 124,263 shares in the company, valued at approximately $4,349,205. The disclosure for this sale can be found here. In the last ninety days, insiders sold 110,726 shares of company stock worth $4,152,374. Insiders own 6.00% of the company’s stock.

Several institutional investors have recently modified their holdings of the company. BlackRock Inc. grew its position in The Ensign Group by 14.1% during the 2nd quarter. BlackRock Inc. now owns 7,187,953 shares of the company’s stock worth $257,471,000 after purchasing an additional 890,137 shares during the last quarter. Wasatch Advisors Inc. grew its position in The Ensign Group by 4.3% during the 1st quarter. Wasatch Advisors Inc. now owns 6,541,631 shares of the company’s stock worth $172,045,000 after purchasing an additional 268,181 shares during the last quarter. Dimensional Fund Advisors LP grew its position in The Ensign Group by 1.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,286,451 shares of the company’s stock worth $60,134,000 after purchasing an additional 23,814 shares during the last quarter. LSV Asset Management grew its position in The Ensign Group by 36.8% during the 1st quarter. LSV Asset Management now owns 1,302,319 shares of the company’s stock worth $34,250,000 after purchasing an additional 350,249 shares during the last quarter. Finally, Copeland Capital Management LLC grew its position in The Ensign Group by 0.5% during the 1st quarter. Copeland Capital Management LLC now owns 1,056,425 shares of the company’s stock worth $27,784,000 after purchasing an additional 5,498 shares during the last quarter. 83.15% of the stock is currently owned by hedge funds and other institutional investors.

About The Ensign Group

The Ensign Group, Inc provides health care services in the post-acute care continuum and other ancillary businesses in the United States. It operates through three segments: Transitional and Skilled Services; Assisted and Independent Living Services; and Home Health and Hospice Services. The Transitional and Skilled Services segment offers a range of medical, nursing, rehabilitative, and pharmacy services, as well as routine services, including daily dietary, social, and recreational services to Medicaid, private pay, managed care, and Medicare payors.

Recommended Story: Asset Allocation Models, Which is Right For You?

Get a free copy of the Zacks research report on The Ensign Group (ENSG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.